ALB MEX Week ended 31 Jul 2026

Weekly Investor Report

Albemarle Corporation · Basic Materials · Specialty Chemicals

Open interactive chart View report data
Latest close 2,050 MXN
1.5% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -28.9% below the Trend Line and sits at 32.6% of its 52-week range. The latest completed week returned 1.5%, after a -12.8% four-week move. The latest news-sentiment score is 49/100.

Setup score 33 out of 100
Latest Close 2,050 MXN 31 Jul 2026
1W Return 1.5% latest completed week
4W Return -12.8% short-term follow-through
12W Return -39.8% quarterly tape
Trend Breadth 75.0% 39 of 52 weeks active
Volume Ratio 3.7x vs 13-week average
What is working
  • Volume is elevated versus the 13-week average, confirming attention.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.5% Latest completed week; four-week move -12.8%. Indicator stack 41/23 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 49/100 30 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -28.9% below the Trend Line and sits at 32.6% of its 52-week range. The latest completed week returned 1.5%, after a -12.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 3.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1912-week average 0.52

12-week confirmation

Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.19Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -12.8% over four weeks, -39.8% over 12 weeks, and 58.4% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W1.5%
4W-12.8%
12W-39.8%
26W-29.9%
52W58.4%
Active trend streak0 weeks
Active weeks in one year39
Trend breadth75.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.52Latest activity-pressure read.
Pressure change6.1%Four-week change in activity pressure.
Leadership-18.07Latest relative-leadership reading.
RS change-267.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment49/100

Weighted news tone is neutral across 30 relevant articles.

5 positive · 24 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-44.2%Distance below the 52-week high.
13-week volatility4.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2615 weeks finished lower.
Best week+13.4%Week of 17 Apr.
Worst week-14.0%Week of 26 Jun.
Latest week+1.5%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains4
Flat weeks2
Modest losses6
Sharp losses9
Recent vol4.8%13-week weekly-return volatility.
Base vol7.2%52-week weekly-return volatility.
Up/down split23/24Count of positive and negative weeks in the 52-week window.
Average skew7.6% / -4.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape37/100

Trend, activity pressure, participation, and risk combine to a 37/100 tape read.

 Indicator analysis30/100

Latest 12-week confirmation: trend 4/12, activity pressure 0/12, relative leadership 6/12.

Activity pressure 0.19; No reversal markers Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment49/100

Weighted news tone is neutral across 30 relevant articles.

Albemarle Corp (ALB) Risk Assessment: Volatility, Financial Risk & Investment Risk Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20262,050 MXN1.5%2,882 MXN2,122 MXN-1.52-18.07750Off
24 Jul 20262,020 MXN-2.4%2,901 MXN2,132 MXN-1.63-18.2619Off
17 Jul 20262,070 MXN-5.4%2,923 MXN2,142 MXN-1.63-16.4033Off
10 Jul 20262,188 MXN-6.9%2,943 MXN2,152 MXN-1.62-11.165Off
3 Jul 20262,350 MXN0.0%2,948 MXN2,164 MXN-1.62-4.9211Off
26 Jun 20262,350 MXN-14.0%2,947 MXN2,175 MXN-1.60-4.4936Off
19 Jun 20262,731 MXN1.5%2,948 MXN2,185 MXN-1.4911.010Off
12 Jun 20262,690 MXN-7.9%2,929 MXN2,192 MXN-1.3310.120Off
5 Jun 20262,921 MXN-4.8%2,911 MXN2,200 MXN-1.1824.080On
29 May 20263,070 MXN4.1%2,873 MXN2,206 MXN-0.6527.4249On
22 May 20262,950 MXN-6.0%2,831 MXN2,208 MXN-0.3024.661.3KOn
15 May 20263,137 MXN-7.9%2,797 MXN2,212 MXN-0.1335.0525On
8 May 20263,404 MXN-0.4%2,750 MXN2,215 MXN0.2344.76404On
1 May 20263,419 MXN4.6%2,692 MXN2,216 MXN0.0752.19269On
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.